Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Llopis
    Junior Member
    • Feb 2014
    • 7

    #1

    A new technology to sequence

    I recently read about Quantum Biosystem which identifies
    base molecules by measuring tunnel current through nano-electrodes as DNA/RNA passes through nanogaps, and by calculating the current difference. Each chip has a nanogap through which only a single strand of DNA or RNA passes, and the device uses nanoelectrodes (one molecule-wide gap between electrodes) to measure tunnel current.
    They have just sequenced the first nucleotides and are available on their web after registration, if anyone want to check how their output looks like.
    I found surprising that they affirm it will be faster than other technologies.
    Do you think this technology has future and if so how will affect other companies?
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Have a look over in this thread for some of the original discussion of Quantum on the forum. They look promising, but things seem far from ready for prime time yet (the read lengths are too short to be usable, but presumably they're working on exactly that). If they can get longer reads then they'll have a nice product. The question will just be one of scalability...

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 12:22 PM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-11-2026, 10:35 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    50 views
    0 reactions
    Last Post SEQadmin2  
    Working...